Doctors are raising concerns about a lesser-known cosmetic issue tied to the boom in GLP-1 weight-loss drugs: temporal hollowing, or a sunken appearance at the temples. The effect is being discussed alongside the broader idea of “Ozempic face,” a term used for facial volume loss that some patients notice after significant weight loss.
According to plastic surgeons cited in the report, more people are now seeking help for this specific change in facial contours. The trend is being linked to widely used GLP-1 medications such as Ozempic, Wegovy and Mounjaro, as patients and doctors pay closer attention to how rapid weight loss can affect the face as well as the body.
The temples are a niche area in cosmetic treatment, but they can make a noticeable difference in overall facial shape. When volume decreases there, it may create a more gaunt or aged look, prompting patients to ask about procedures aimed at restoring fullness.
The growing attention to Ozempic temporal hollowing reflects a wider conversation around the side effects and appearance changes associated with GLP-1 medications. While these drugs remain popular for weight loss and diabetes care, doctors appear to be warning that cosmetic changes, including hollow temples, are becoming a more common part of the discussion.
